Stem Cell Therapeutics Corp.
3 clinical trials · Sponsor
◉ Watch Stem Cell Therapeutics Corp.
| Record | Firm | Date |
|---|---|---|
| Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (NCT00938314) | Stem Cell Therapeutics Corp. | 2009-08-01 |
| REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (NCT00715364) | Stem Cell Therapeutics Corp. | 2009-08-01 |
| REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (NCT00663416) | Stem Cell Therapeutics Corp. | 2008-03-01 |
Track Stem Cell Therapeutics Corp. automatically
Every clearance here is in the API, with alerts when new ones post.